FIELD: medicine.
SUBSTANCE: invention refers to medicine. What is described is a haemostatic device for blood coagulation improvement which contains a gauze base, a clay material located thereon, and also polyol, such as glycerol or similar placed on the gauze base for binding the clay material. The device for bleeding wound management comprises at least a portion of the clay material contacting to blood flowing from the wound to cause coagulation. A dressing applicable on the bleeding wound for blood coagulation improvement comprises a flexible base and a gauze base located thereon. The gauze base comprises the clay material and polyol. Ahaemostatic sponge also contains a gauze basis and a disperse system of the haemostatic material and polyol on the first base surface. The invention also refers to N-substituted monomers and polymers, methods for producing such monomers and polymers and to methods for using for various medical purposes, e.g. in medical devices. In the preferential versions, a medical device represents a stent.
EFFECT: haemostatic device improves blood coagulation.
43 cl, 1 tbl, 9 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
HEMOSTATIC DEVICE | 2013 |
|
RU2599033C2 |
HAEMOSTATIC AGENT BASED ON POLYVINYLPYRROLIDONE AND METHODS FOR PREPARING ITS PHARMACOLOGICAL FORMS | 2018 |
|
RU2705812C1 |
HAEMOSTATIC MATERIAL | 2012 |
|
RU2824974C2 |
HAEMOSTATIC SPONGE | 2011 |
|
RU2562569C2 |
HEMOSTATIC MATERIAL, HEMOSTATIC MEANS AND MATERIAL BASED THEREON | 2016 |
|
RU2635465C1 |
HAEMOSTATIC AGENT BASED ON CHITOSAN SUCCINATE AND CALENDULA EXTRACT | 2019 |
|
RU2694372C1 |
MEDICINAL MATERIAL AND PRODUCTS BASED UPON THIS MATERIAL | 2002 |
|
RU2249467C2 |
WOUND COVER WITH HEMOSTATIC ACTION, AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2624242C1 |
HAEMOSTATIC AGENT | 2023 |
|
RU2826361C1 |
COMPOSITION FOR TEMPORARY CONTROL OF BLEEDING | 2023 |
|
RU2819603C1 |
Authors
Dates
2012-06-20—Published
2008-03-06—Filed